Latest Working Capital Management News

AdNeo Limited (ASX: AD1) nearly doubled operating revenue in FY26 and delivered its first full-year operating cash inflow, marking a sharp turnaround after the Learnt Global acquisition. The recovery remains incomplete, with a $3.97 million loss, significant current liabilities and an auditor-drawn material uncertainty over going concern.

SciDev Limited (ASX:SDV) finished FY26 with a sharp annual earnings decline, but a leaner business and stronger second-half performance offer a potential reset. Revenue fell 17% and underlying EBITDA dropped 49%, while the company exited loss-making international operations and rebuilt net cash to $6.8 million.

Alfabs Australia’s FY26 reset preserved free cash flow despite a sharp earnings decline, while Mining growth and debt refinancing form the bridge to a potential dividend restart. The company enters FY27 leaner, but the plan still depends on execution, cash conversion and Phase II debt restructuring.

Nufarm expects FY26 underlying EBITDA to rise about 25% at the midpoint of its $370 million to $380 million range, while leverage falls from 2.7 times to approximately 2.0 times. The improvement comes alongside a sweeping cost-reduction program, but restructuring charges of up to $110 million post tax remain in the numbers.

Acumentis delivered a sharp improvement in profit and cash generation despite lower revenue, supported by cost control and diversification beyond mortgage valuations. The result comes with a governance complication: a Section 249D requisition seeking to replace the chairman and managing director.

Altitude Minerals has secured a $1.215 million placement and plans a further $1.487 million rights issue to fund drilling at its Nevada gold-silver projects. The raising offers free options, but shareholders who do not participate in the non-renounceable offer face dilution.

Prestal Holdings Limited posted a 30% drop in sales to $10.3 million and a $3.6 million net loss for FY26, while exiting its core Hampers With Bite business in a strategic pivot.

BLS Pharmaceuticals (ASX: BLS) reported a standout FY26 with revenue surging 161% to $74.2 million and net profit more than tripling to $15.4 million, driven by expanded manufacturing and major international contracts including a $50 million German supply deal.

Audeara Limited delivered record FY26 revenue of $4.45 million, driven by a 45% surge in Australian wholesale sales and progress in AI audio licensing with OPTEK Microelectronics. The company narrowed its loss and advanced Auracast deployments across retirement villages and education sectors.

SSH Group delivered a 23% revenue increase and 79% profit rise in FY26, fueled by the strategic acquisition of Elphinstone Mechanical Services and strengthened partnerships.

Michael Hill International delivered a landmark FY26 with record revenue of AU$655.7 million, a 57% jump in comparable EBIT, and reinstated dividends after a strategic turnaround.

Michael Hill International reported a 1.9% revenue increase to $655.7 million in FY26, with comparable EBIT up 57% to $24 million and net profit soaring 376%. The company restored dividends and announced a Chair succession.